271 related articles for article (PubMed ID: 20609572)
1. Dietary phosphate restriction in dialysis patients: a new approach for the treatment of hyperphosphataemia.
Guida B; Piccoli A; Trio R; Laccetti R; Nastasi A; Paglione A; Memoli A; Memoli B
Nutr Metab Cardiovasc Dis; 2011 Nov; 21(11):879-84. PubMed ID: 20609572
[TBL] [Abstract][Full Text] [Related]
2. Dietary habits and counseling focused on phosphate intake in hemodialysis patients with hyperphosphatemia.
Cupisti A; D'Alessandro C; Baldi R; Barsotti G
J Ren Nutr; 2004 Oct; 14(4):220-5. PubMed ID: 15483782
[TBL] [Abstract][Full Text] [Related]
3. Low prevalence of hyperphosphatemia independent of residual renal function in peritoneal dialysis patients.
Dong J; Wang H; Wang M
J Ren Nutr; 2007 Nov; 17(6):389-96. PubMed ID: 17971311
[TBL] [Abstract][Full Text] [Related]
4. Dietary intervention focused on phosphate intake in hemodialysis patients with hyperphosphoremia.
Lou LM; Caverni A; Gimeno JA; Moreno R; Pérez J; Alvarez R; Campos B; García M; Gutiérrez A; Bielsa S; Castilla J; Sanz A; Martin F;
Clin Nephrol; 2012 Jun; 77(6):476-83. PubMed ID: 22595390
[TBL] [Abstract][Full Text] [Related]
5. Effect of prescribing a high protein diet and increasing the dose of dialysis on nutrition in stable chronic haemodialysis patients: a randomized, controlled trial.
Kloppenburg WD; Stegeman CA; Hovinga TK; Vastenburg G; Vos P; de Jong PE; Huisman RM
Nephrol Dial Transplant; 2004 May; 19(5):1212-23. PubMed ID: 14993506
[TBL] [Abstract][Full Text] [Related]
6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
7. Phosphate control in chronic uremia: don't forget diet.
Cupisti A; Morelli E; D'Alessandro C; Lupetti S; Barsotti G
J Nephrol; 2003; 16(1):29-33. PubMed ID: 12649532
[TBL] [Abstract][Full Text] [Related]
8. Failure of dietary protein and phosphate restriction to retard the rate of progression of chronic renal failure: a prospective, randomized, controlled trial.
Williams PS; Stevens ME; Fass G; Irons L; Bone JM
Q J Med; 1991 Oct; 81(294):837-55. PubMed ID: 1801057
[TBL] [Abstract][Full Text] [Related]
9. Continuous ambulatory peritoneal dialysis patients are unable to increase dietary intake to recommended levels.
Sutton D; Higgins B; Stevens JM
J Ren Nutr; 2007 Sep; 17(5):329-35. PubMed ID: 17720102
[TBL] [Abstract][Full Text] [Related]
10. Management of hyperphosphataemia: practices and perspectives amongst the renal care community.
Nagel CJ; Casal MC; Lindley E; Rogers S; Pancířová J; Kernc J; Copley JB; Fouque D
J Ren Care; 2014 Dec; 40(4):230-8. PubMed ID: 24814866
[TBL] [Abstract][Full Text] [Related]
11. Oral activated charcoal suppresses hyperphosphataemia in haemodialysis patients.
Wang Z; Cui M; Tang L; Li W; Wei Y; Zhu Z; Jia X; Kong X; Xu D
Nephrology (Carlton); 2012 Sep; 17(7):616-20. PubMed ID: 22697887
[TBL] [Abstract][Full Text] [Related]
12. More dietetic time, better outcome? A randomized prospective study investigating the effect of more dietetic time on phosphate control in end-stage kidney failure haemodialysis patients.
Morey B; Walker R; Davenport A
Nephron Clin Pract; 2008; 109(3):c173-80. PubMed ID: 18663331
[TBL] [Abstract][Full Text] [Related]
13. [Daily nutrient intake in hemodialysis].
Bellizzi V; Di Iorio BR; Zamboli P; Terracciano V; Minutolo R; Iodice C; De Nicola L; Conte G
G Ital Nefrol; 2003; 20(6):592-601. PubMed ID: 14732911
[TBL] [Abstract][Full Text] [Related]
14. Use of a renal-specific oral supplement by haemodialysis patients with low protein intake does not increase the need for phosphate binders and may prevent a decline in nutritional status and quality of life.
Fouque D; McKenzie J; de Mutsert R; Azar R; Teta D; Plauth M; Cano N;
Nephrol Dial Transplant; 2008 Sep; 23(9):2902-10. PubMed ID: 18408077
[TBL] [Abstract][Full Text] [Related]
15. Effects of phosphorus/calcium-restricted and phosphorus/calcium-replete 32% protein diets in dogs with chronic renal failure.
Finco DR; Brown SA; Crowell WA; Groves CA; Duncan JR; Barsanti JA
Am J Vet Res; 1992 Jan; 53(1):157-63. PubMed ID: 1539911
[TBL] [Abstract][Full Text] [Related]
16. Effect of boiling on dietary phosphate and nitrogen intake.
Cupisti A; Comar F; Benini O; Lupetti S; D'Alessandro C; Barsotti G; Gianfaldoni D
J Ren Nutr; 2006 Jan; 16(1):36-40. PubMed ID: 16414439
[TBL] [Abstract][Full Text] [Related]
17. Patient education: an efficient adjuvant therapy for hyperphosphatemia in hemodialysis patients.
Sun CY; Chang KC; Chen SH; Chang CT; Wu MS
Ren Fail; 2008; 30(1):57-62. PubMed ID: 18197544
[TBL] [Abstract][Full Text] [Related]
18. Implementation of standardized nutrition guidelines by renal dietitians is associated with improved nutrition status.
Campbell KL; Ash S; Zabel R; McFarlane C; Juffs P; Bauer JD
J Ren Nutr; 2009 Mar; 19(2):136-44. PubMed ID: 19218040
[TBL] [Abstract][Full Text] [Related]
19. [Phosphate metabolism and nutritional therapy in predialysis patients].
Hamada Y; Usami M
Clin Calcium; 2012 Oct; 22(10):1577-82. PubMed ID: 23023639
[TBL] [Abstract][Full Text] [Related]
20. Dietary phosphorus restriction in advanced chronic kidney disease: merits, challenges, and emerging strategies.
Gutiérrez OM; Wolf M
Semin Dial; 2010; 23(4):401-6. PubMed ID: 20557490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
